Abstract
Introduction

Turner syndrome is a disorder in women with absence of a normal second sex chromosome. The typical clinical features are short stature, gonadal dysgenesis and some anatomical anomaly. This syndrome involves mental retardation, natural abortion, autoimmune disease, impaired hearing, and multiple pigmented nevi. Endocrinologically, hypogonadism, autoimmune thyroid diseases, and diabetes mellitus are often manifested. Major karyotype is monosomy X (45,X), and 5 to 10% have a duplication of the long arm of one X (46,X,i (Xq)). Most of the rest have mosaicism for 45,X, and 3 to 4% are mosaic for a triple X (47,XXX) (1-5).
Acromegaly is a rare disease caused by excess of GH secretion, resulting from a pituitary tumor in more than 99% of all cases. Oversecretion of GH develops not only overgrowth of soft tissue and bone but also hormonal and metabolic changes (6 
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Discussion
Clinical characteristics in our case are shown in Table 5 .
The karyotype determined by X chromosome is linked to the difference in clinical features. Congenital malformations are found more frequently among women with the 45,X karyotype, whereas endocrine disease, acquired heart disease, hypertension, and arteriosclerosis are more frequent in women with other karyotype of Turner syndrome (5). Nonmosaic triple X is generally associated with increased stat-
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Types of tumor Karyotype Reference microprolactinoma 45,X/46,XX [16] macroadenoma 45,X [17] microadenoma not described [18] macroadenoma 45,X [19] prolactinoma 45,X/46,XX [20] ACTH-producing microadenoma not described [21] GH-producing macroadenoma 45,X/46,X,i(X) (q10) [22] (3, 23) . GH insensitivity resulting from IGF-I insensitivity in Turner syndrome is supposedly due to defects in SHOX gene (24) . The estimation on the spontaneous and stimulated GH secretion in Turner syndrome is equivocal because it is affected by secretion of estrogen. Decreased circulating levels of estrogen does not preserve GH secretion (25) . However, our patient seems to have secreted estrogen sufficiently because she had her periods before the tumor developed. Therefore GH secretion may have been promoted probably because of increased GHRH secretion if she was in a state of GH/IGF-I insensitivity (26, 27) . A previous study showed that excessive GH secretion resulted in upregulated somatotrope proliferation and neoplastic transformation in animal models and human (28) . In addition to some genetic events in neoplastic transformation, increased GHRH secretion has a possible role for somatotrope tumorigenesis. A case report of acromegaly in a patient with anorexia nervosa, which causes functional GH insensitivity, is meaningful and helpful to consider somatotrope tumorigenesis in GH insensitivity syndrome (29) . We believe that the present case is highly suggestive to elucidate the mechanism of GH/IGF-I action in Turner syndrome. Accumulating similar cases is needed to clarify the important relationships between GH/IGF-I and Turner syndrome.
